Pain and Functional Recovery After Mastectomy and IBR by Implant: Prepectoral Versus Subpectoral Technique
DREAM-RMI
Prospective Study Evaluating Postoperative Pain and Functional Recovery After Mastectomy and Immediate Breast Reconstruction by Implant: Prepectoral Versus Subpectoral Technique
1 other identifier
observational
27
1 country
1
Brief Summary
This is a prospective, single-center, non-randomized study of immediate breast reconstruction (IBR) using a pre- or retro-pectoral technique in patients with breast cancer who have undergone total mastectomy. The technique used is chosen according to the characteristics of the breast, the morphology of the patient and her wishes after informed information on the different techniques. The aim is not to compare the two techniques but rather to evaluate the early functional results of these two methods in order to better understand them and to propose a management adapted to each. The main objective will be to evaluate the postoperative pain by BPI questionnaire. The investigators also wish to observe the functional results of the homolateral upper limb by DASH questionnaire, the quality of life by BREAST Q questionnaire and the occurrence of complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2022
CompletedFirst Posted
Study publicly available on registry
September 6, 2022
CompletedStudy Start
First participant enrolled
September 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2023
CompletedFebruary 13, 2026
September 1, 2023
1.2 years
August 29, 2022
February 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Describe postoperative pain and functional results
Brief Pain Inventory (BPI) short form - 4 scales from 1 (No pain) to 10 (max pain) + 7 scales from 1 (no discomfort) to 10 (max discomfort) to determine if the pain interfered with activities of daily living
6 month
Secondary Outcomes (7)
Assessing quality of life and aesthetic satisfaction
6 months
Evaluate the function of the homolateral upper limb
6 months
Describe the occurrence of postoperative complications
3 months
Describe the length of operative stay (for the initial reconstruction), for all patients and according to the methods of reconstruction performed
3 months
Describe the duration of drainage for all patients and according to the methods of reconstruction performed
3 months
- +2 more secondary outcomes
Study Arms (2)
pre-pectoral prosthesis
breast cancer patients with an indication for total mastectomy + immediate breast reconstruction (IBR) by prosthesis using a pre-pectoral technique
retropectoral prosthesis
breast cancer patients with an indication for total mastectomy + immediate breast reconstruction (IBR) by prosthesis using the retropectoral technique
Interventions
pre- or retro pectoral prosthesis
Eligibility Criteria
Major patients followed for breast cancer with indication of mastectomy with immediate breast reconstruction by prosthesis.
You may qualify if:
- Major patients
- With breast cancer and indication for total mastectomy
- With a desire for immediate breast reconstruction
- Total mastectomy procedure and Immediate Breast Reconstruction by Pre-pectoral or Retro-Pectoral prosthesis
- Information of the patient and collection of his/her non-opposition
- Affiliation with a social securitý scheme, or beneficiary of such a scheme
You may not qualify if:
- Prophylactic mastectomies
- Metastatic patients
- Patients requiring another surgical technique
- Person in an emergency situation, person of legal age under legal protection (adult under guardianship, curators or safeguard of justice), or unable to express consent,
- Impossibility to submit to the medical follow-up of the trial for geographical, social or psychological reasons
- Pregnant or likely to be pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institut de Cancerologie de L'Ouest
Saint-Herblain, 44805, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Céline RENAUDEAU, MD
celine.renaudeau@ico.unicancer.fr
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2022
First Posted
September 6, 2022
Study Start
September 7, 2022
Primary Completion
November 30, 2023
Study Completion
November 30, 2023
Last Updated
February 13, 2026
Record last verified: 2023-09